CereVasc

United States
Newell, Iowa, United States, 02466

Company profile

CereVasc company profile

CereVasc is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Current treatment of these patients requires an invasive, neurosurgical procedure with a documented rate of success well below the success rate for other neurosurgical interventions. The eShunt System has the potential to significantly improve patient outcomes and substantially decrease the overall cost of surgical treatment of this life-threatening condition.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2014-01-01

Headquarters

Postal code
02466
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$114M
Last funding
Series B / $70M / 2024-05-13
Last equity funding
Series B / $70M
Investors
3
Lead investors
3
Founders
4
Articles
53

Founders and investors

Founders

Adel MalekCarl HeilmanDaniel LevangiePatrick Sullivan

Lead investors

ATON PartnersBain Capital Life SciencesPerceptive Advisors

Investors

ATON PartnersBain Capital Life SciencesPerceptive Advisors